A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing proteins that may be more effective than the CRISPR-Cas9 systems that underpin most contemporary gene editing therapies.
Photo illustration—Getty Images